VIR · US market

Vir Biotechnology Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$1.91bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-7.59×

Latest-quarter run-rate P/E5.96×

Trailing P/S6.30×

Latest-quarter run-rate P/S2.00×

Calculation inputs

Trailing earnings: -US$251.68m
Latest-quarter run-rate earnings: US$320.32m
Latest fiscal-year earnings: -US$437.99m
Trailing revenue: US$303.23m
Latest-quarter run-rate revenue: US$955.78m
Latest fiscal-year revenue: US$68.56m

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

IDNA · iShares Genomics Immunology and Healthcare ETF1.20% weight · Holdings dated 21 August 2026
GNOM · Global X Genomics & Biotechnology ETF1.08% weight · Holdings dated 31 May 2026
PSCH · Invesco S&P SmallCap Health Care ETF0.57% weight · Holdings dated 31 May 2026
XBI · State Street SPDR S&P Biotech ETF0.44% weight · Holdings dated 21 August 2026
QQQS · Invesco NASDAQ Future Gen 200 ETF0.43% weight · Holdings dated 31 May 2026
CTSOX · Calamos Timpani Small Cap Growth Fund Class R60.29% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
VSTCX · Vanguard Strategic Small-Cap Equity Fund0.28% weight · Holdings dated 30 June 2026
BOGIX · SGI Small Cap Core Fund Class I Shares0.26% weight · Holdings dated 31 May 2026
FSSLX · Fidelity Series Small Cap Core Fund0.25% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
SWSCX · Schwab Small-Cap Equity Fund0.23% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.